IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v42y2019i9d10.1007_s40264-019-00837-y.html
   My bibliography  Save this article

Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study

Author

Listed:
  • Wiebke Schäfer

    (Leibniz Institute for Prevention Research and Epidemiology)

  • Christina Princk

    (Leibniz Institute for Prevention Research and Epidemiology)

  • Bianca Kollhorst

    (Leibniz Institute for Prevention Research and Epidemiology)

  • Tania Schink

    (Leibniz Institute for Prevention Research and Epidemiology)

Abstract

Background and Purpose Selective serotonin reuptake inhibitors (SSRIs) are frequently prescribed in the elderly due to a more favorable risk profile than other antidepressants (ADs). However, SSRIs are associated with an increased risk of gastrointestinal bleeding, while evidence on the risk of hemorrhagic stroke (HS) is limited. Therefore, we compared the risk of HS associated with the use of ADs in the elderly. Methods Based on data from the German Pharmacoepidemiological Research Database (GePaRD), a case–control study matched on age, sex, and health insurance provider, nested in a cohort of incident users of ADs ≥ 65 years of age was performed. Cases were identified from hospital discharge diagnoses, and exposure was identified from outpatient prescriptions. Multivariable conditional logistic regression was used to estimate adjusted odds ratios (ORs) with 95% confidence intervals (CIs). Results Based on 4059 cases and 40,590 controls, an increased risk of HS was found in current use of SSRIs (OR 1.39, 95% CI 1.22–1.58), selective serotonin and noradrenaline reuptake inhibitors (1.69, 1.35–2.11), noradrenergic and specific serotonergic ADs (1.44, 1.22–1.69), and noradrenaline reuptake inhibitors (3.81, 1.54–9.43) compared with tri- and tetracyclic antidepressants. An increased risk of HS was seen in patients with a high baseline risk of bleeding and in patients with depression. The risk of HS varied between individual ADs. Conclusion Our study shows that the use of medications inhibiting serotonin and/or noradrenaline reuptake increases the risk of HS in patients aged 65 years and older and that the risk varies across individual ADs.

Suggested Citation

  • Wiebke Schäfer & Christina Princk & Bianca Kollhorst & Tania Schink, 2019. "Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case–Control Study," Drug Safety, Springer, vol. 42(9), pages 1081-1089, September.
    • Handle: RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00837-y
    DOI: 10.1007/s40264-019-00837-y
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-019-00837-y
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-019-00837-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Kathrin Jobski & Bianca Kollhorst & Edeltraut Garbe & Tania Schink, 2017. "The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone–Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case–Control Study," Drug Safety, Springer, vol. 40(6), pages 505-515, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Oluwabunmi Ogungbe & Luma Akil & Hafiz A. Ahmad, 2019. "Exploring Unconventional Risk-Factors for Cardiovascular Diseases: Has Opioid Therapy Been Overlooked?," IJERPH, MDPI, vol. 16(14), pages 1-10, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00837-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.